The purpose of this study was to identify changes in protein expression that occur in the hippocampus in Alzheimer's disease (AD). To achieve this, we performed a quantitative analysis comparing the protein levels from hippocampi of subjects with AD to aged-matched normal subjects. First, synaptoneurosome samples were prepared from hippocampal slices from deceased human patients. Then the samples were sent to the Mass Spectrometry Core, where they were analyzed to identify proteomic changes in expression of the sample tissue. The software Scaffold was used to validate MS/MS based peptide and protein identifications. Using the quantitative analysis of Scaffold, enrichment analysis was run using genes identified by Scaffold. From here identif...
Alzheimer's disease (AD) is the most common form of dementia; however, mechanisms and biomarkers rem...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Abstract Background The complicated cellular and biochemical changes that occur in brain during Alzh...
Abstract Background Alzheimer’s disease (AD) is the m...
This study is aimed at gaining insights into the brain site-specific proteomic senescence signature ...
Brain tissue from Alzheimer's disease (AD) patients shows significant loss of synapses in selected r...
Alzheimer’s disease (AD) is the most prevalent form of dementia affecting the elderly, and as the ag...
Proteomics involves the identification of unknown proteins following their separation, often using t...
INTRODUCTION: We performed a comprehensive quantitative proteomics study on human hippocampus tissue...
INTRODUCTION: We performed a comprehensive quantitative proteomics study on human hippocampus tissue...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Alzheimer's disease (AD) is the most common type of dementia, comprising 60-80% of all reported case...
Background: Synaptic dysfunction occurs early in Alzheimer's disease (AD) and is recognized to be a ...
Identification of oxidized proteins in Alzheimer's disease (AD) brain is hypothesized to lead to new...
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia world...
Alzheimer's disease (AD) is the most common form of dementia; however, mechanisms and biomarkers rem...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Abstract Background The complicated cellular and biochemical changes that occur in brain during Alzh...
Abstract Background Alzheimer’s disease (AD) is the m...
This study is aimed at gaining insights into the brain site-specific proteomic senescence signature ...
Brain tissue from Alzheimer's disease (AD) patients shows significant loss of synapses in selected r...
Alzheimer’s disease (AD) is the most prevalent form of dementia affecting the elderly, and as the ag...
Proteomics involves the identification of unknown proteins following their separation, often using t...
INTRODUCTION: We performed a comprehensive quantitative proteomics study on human hippocampus tissue...
INTRODUCTION: We performed a comprehensive quantitative proteomics study on human hippocampus tissue...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Alzheimer's disease (AD) is the most common type of dementia, comprising 60-80% of all reported case...
Background: Synaptic dysfunction occurs early in Alzheimer's disease (AD) and is recognized to be a ...
Identification of oxidized proteins in Alzheimer's disease (AD) brain is hypothesized to lead to new...
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia world...
Alzheimer's disease (AD) is the most common form of dementia; however, mechanisms and biomarkers rem...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Abstract Background The complicated cellular and biochemical changes that occur in brain during Alzh...